» Articles » PMID: 24793460

Sudden Cardiac Arrest Recorded During Holter Monitoring: Prevalence, Antecedent Electrical Events, and Outcomes

Abstract

Background: Causative arrhythmias of sudden cardiac arrest (SCA) are changing in this age of improved coronary care.

Objective: The purpose of this study was to examine the frequency of terminal arrhythmias and the electrical events prior to SCA.

Methods: We analyzed 24-hour Holter recordings of 132 patients enrolled from 41 institutions who either died (n = 88) or had an aborted death (n = 44). The Holter recordings were obtained for diagnosing and evaluating diseases and arrhythmias in those without any episodes suggestive of SCA.

Results: In 97 patients (73%), SCA was associated with ventricular tachyarrhythmias and in 35 (27%) with bradyarrhythmias. The bradyarrhythmia-related SCA patients were older than those with a tachyarrhythmia-related SCA (70 ± 13 years vs. 58 ± 19 years, P < .001). The most common arrhythmia for a tachyarrhythmia-related SCA was ventricular tachycardia degenerating to ventricular fibrillation (45%). The bradyarrhythmia-related SCA was caused by asystole (74%) or AV block (26%). Spontaneous conversion was observed in 37 patients (38%) with ventricular tachyarrhythmias. Of those, 62% of the patients experienced symptoms including syncope, chest pain, or convulsion. Multivariate logistic analysis revealed that independent predictors of mortality for tachyarrhythmia-related SCAs were advanced age (odds ratio 1.04, 95% confidence interval 1.02-1.08) and ST elevation within the hour before SCA (odds ratio 3.54, 95% confidence interval 1.07-13.5). In contrast, the presence of preceding torsades de pointes was associated with spontaneous conversion (odds ratio 0.20, 95% confidence interval 0.05-0.66).

Conclusion: The most frequent cause of SCA remains ventricular tachyarrhythmias. Advanced age and ST elevation before SCA are risk factors for mortality in tachyarrhythmia-related SCAs.

Citing Articles

Redefining outcomes of ventricular arrhythmia for SGLT2 inhibitor medication in heart failure patients: a meta-analysis of randomized controlled trials.

Lin M, Zhang S, Zhang L, Yang C, Luo Y, Peng Y Syst Rev. 2025; 14(1):31.

PMID: 39893467 PMC: 11786358. DOI: 10.1186/s13643-025-02766-7.


Remodeling of the Intracardiac Ganglia During the Development of Cardiovascular Autonomic Dysfunction in Type 2 Diabetes: Molecular Mechanisms and Therapeutics.

Evans A, Li Y Int J Mol Sci. 2024; 25(22).

PMID: 39596529 PMC: 11594459. DOI: 10.3390/ijms252212464.


Leukotriene B4 is elevated in diabetes and promotes ventricular arrhythmogenesis in guinea pig.

Corbin A, Aromolaran K, Aromolaran A J Cell Physiol. 2024; 240(1):e31467.

PMID: 39402808 PMC: 11733858. DOI: 10.1002/jcp.31467.


JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia.

Takase B, Ikeda T, Shimizu W, Abe H, Aiba T, Chinushi M J Arrhythm. 2024; 40(4):655-752.

PMID: 39139890 PMC: 11317726. DOI: 10.1002/joa3.13052.


Leukotriene B4 signaling in diabetic ventricular arrhythmias.

Aromolaran A J Cell Physiol. 2024; 239(8):e31277.

PMID: 38606714 PMC: 11324383. DOI: 10.1002/jcp.31277.